Company & Sponsor Intelligence
VA Office of Research and Development
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting1
Completed4
Countries1
Therapeutic footprint
parkinsonsstrokeunclassified
Indexed studies
NCT01259427Reducing Internalized Stigma in People With Serious Mental Illness
depression · United StatesPHASE2
depression · United StatesPHASE2
NCT02248649Telemedicine Intervention to Improve Cognitive Function
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT04429945Immersive Virtual Reality in Stroke Pilot Study
stroke · United StatesNA
stroke · United StatesNA
NCT02667392Biofeedback to Increase Propulsion During Walking After Stroke
stroke · United StatesPHASE1
stroke · United StatesPHASE1
NCT02132650Rehabilitating Corticospinal Control of Walking
stroke · United StatesNA
stroke · United StatesNA
NCT05410392Telemedicine Intervention in Patients With Chronic Pain in PD
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT04221750Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors
unclassified · United StatesPHASE3
unclassified · United StatesPHASE3
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →